Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Artist & Activist Domenic Esposito Announces Solo Exhibition at Piano Craft Gallery in Boston

Artist and social activist Domenic Esposito launches his solo exhibition Vox Clamantis at Piano Craft Gallery (Jan. 7-30, 2022). He first achieved national attention with massive opioid spoon sculptures, and will now showcase his wider body of work, including sculptures and paintings reflecting the "collateral damage of opioid addiction" through the unique lens of the artist.


News provided by

Domenic Esposito

Dec 14, 2021, 15:00 ET

Share this article

Share toX

Share this article

Share toX


BOSTON, Dec. 14, 2021 /PRNewswire-PRWeb/ -- Artist and social activist Domenic Esposito will launch his solo exhibition Vox Clamantis at Piano Craft Gallery in Boston (Jan. 7-30, 2022), with an opening night reception on Friday, Jan. 7 (special media preview hour at 5pm; free and open to the public, 6-9pm; register here for the event). In 2018, Domenic achieved national recognition with massive opioid spoon sculptures placed on the doorsteps of the FDA and major pharmaceutical giants. Now, for the first time, audiences will be able to see his wider body of work, including a selection of cast and assembled sculptures and paintings. Through his work, he shares the underlying "collateral damage of opioid addiction" and what it means for all those affected both directly and indirectly by this tragic, destructive force.

"Human connection is so powerful, and the past couple of years have tested us in many ways individually and as a society," says artist Domenic Esposito. "The need to be seen, heard and understood is something we all crave, even the addict that society has dismissed. So, for all those struggling with opioid addiction and the loved ones who suffer along with them, finding the way back to being connected and visible becomes the greatest struggle, and they all deserve our compassion."

“Human connection is so powerful — the need to be seen, heard and understood is something we all crave, especially those struggling with opioid addiction and the loved ones who suffer along with them — they all deserve our compassion," says artist Domenic Esposito.

Post this

Vox Clamantis ('the voice of one crying out') will feature more than twenty works, including Unconditional, 2020 (Oil on canvas, cast bronze 40" x 30" x 12"), Assailable, 2020 (Oil on canvas, cast bronze 40" x 30" x 12"), Mass, 2021 (Oil on canvas 48" x 72"), Cass, 2021 (Oil on canvas 48" x 72") and on loan, Reticent and Marching (both 2021, Oil on canvas) courtesy of The Eileen S. Kaminsky Family Foundation. The exhibition narrates the snapshots of thoughts and feelings the artist has experienced through his own tormented journey playing the role of intermediary, protector and savior in his brother's struggle with addiction, isolation and detachment from family and society.

"As activist, Domenic Esposito is compelling and certainly a force in a movement that continues to seek justice," says Diana Lada L'Henaff, Exhibition Curator. "As an artist, he is thoughtful, nuanced and very compassionate about presenting a subject matter that is daunting to most. Using a type of visual shorthand, he shares what consumes him internally and hopes to confront the viewer with subtle reminders of what needs to be addressed collectively."

During this month-long exhibit at Piano Craft Gallery, there will also be a few events with artists, authors and academics in connection to Domenic's art and activism. See full lineup at The Opioid Spoon Project.

  • Friday, Jan. 21 the Opioid Spoon Project will host a fundraiser event (5-9pm).
  • Saturday, Jan. 22, noted journalist and author Sam Quinones, will discuss his latest book The Least of Us: True Tales of America and Hope in the Time of Fentanyl and Meth, which follows his previous book, the New York Times bestseller Dreamland: The True Tale of America's Opiate Epidemic, (2-3pm).
  • Sunday, Jan. 23, Domenic will conduct a 2D Art with 3D Sculpture Workshop, co-sponsored by New England Sculptors Association (NESA).
  • Thursday, Jan. 27, Exploring Art Therapy, to discuss the healing power of art, featuring Antonella Pirone, PHD, Director of Translational Pharmacology at Caesura Tx, SLP fellow and Alicia Ventura, Director of Special Projects & Research, Office-Based Addiction Treatment Program (OBAT) at Boston Medical Center. Sponsored by Professionisti Italiani a Boston (PIB), (6-8pm).
  • Saturday, Jan. 29, Artist Talk with Domenic Esposito and Vox Clamantis Curator Diana Lada L'Henaff (6-7pm).

About Domenic Esposito Fine Art
A Massachusetts based artist and social activist, art has been an integral part of Domenic's Iife since childhood. A graduate of Northeastern University, he was also trained in art from the Massachusetts College of Art and Design, Stonybrook Fine Arts, Artist Asylum and Prospect Hill Forge, where he developed his metalwork skills. Considered a sculptor first, he continues to refine his craft with deliberate vocabulary borrowed from the Italian Renaissance period, as well as his own personal cultivation of Asian culture and principles. In 2018, he achieved national attention through the massive opioid spoon sculptures he placed on the doorsteps of the FDA and major pharmaceutical giants, and founded the Opioid Spoon Project, a 501(c)(3) to serve as a solution-based platform that seeks legal justice and brings voice to the devastation of opioid addiction.

Domenic's work includes sculptures, paintings, commissions and public art installations, and has been privately collected and exhibited in a range of galleries and art fairs across the U.S., including Canvas Fine Arts, Boston; Piano Craft Gallery, Boston; Insight Artspace, NY; Scope, NYC; Art Palm Beach; and SOFA Chicago Art Fair, among others. In 2019, his work Accountability won 'Best in Show' at the Arts Benicia Juried Show in California. He also completed a prestigious artist residency at Mana Contemporary, which lead to his print work with legendary Gary Lichtenstein. To learn more follow on Facebook and Instagram.

About Piano Craft Gallery
The Piano Craft Gallery, Inc. works to eliminate common barriers to accessing the arts such as race, education level and class by guiding our operation through an anti-racist and inclusive lens. It does this by sharing, promoting and celebrating the work of racially, culturally and socio-economically diverse artists of all abilities with the public. For more information, visit Facebook, Twitter and Instagram.

Media Contact for Domenic Esposito
Roberta Tsang, RTPR
[email protected]

Media Contact

Roberta Tsang, RTPR, 617-306-0823, [email protected]

SOURCE Domenic Esposito

Modal title

Assailable, 2021, Oil on canvas and bronze
Assailable, 2021, Oil on canvas and bronze
Assailable, 2021, Oil on canvas and bronze

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.